advertisement
Bicket AK 46
Showing records 1 to 25 | Display all abstracts from Bicket AK125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
Stein JD
Ophthalmology science 2025; 5: 100717
125672 Time spent on eye disease screening, optical care, and care navigation within a federally qualified health center
Weber MK
AJO international 2025; 2:
125065 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs
Newman-Casey PA
Ophthalmology 2025; 132: 1033-1044
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Silverstein SM
Drugs 2025; 85: 557-570
125672 Time spent on eye disease screening, optical care, and care navigation within a federally qualified health center
Woodward MA
AJO international 2025; 2:
125065 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs
Niziol LM
Ophthalmology 2025; 132: 1033-1044
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Oddone F
Drugs 2025; 85: 557-570
125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
An HS
Ophthalmology science 2025; 5: 100717
125672 Time spent on eye disease screening, optical care, and care navigation within a federally qualified health center
Lu MC
AJO international 2025; 2:
125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
Andrews CA
Ophthalmology science 2025; 5: 100717
125065 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs
Elam AR
Ophthalmology 2025; 132: 1033-1044
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Kolko M
Drugs 2025; 85: 557-570
125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
Andrews CA
Ophthalmology science 2025; 5: 100717
125672 Time spent on eye disease screening, optical care, and care navigation within a federally qualified health center
Niziol LM
AJO international 2025; 2:
125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
Pershing S
Ophthalmology science 2025; 5: 100717
125065 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs
Bicket AK
Ophthalmology 2025; 132: 1033-1044
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Brinkmann CK
Drugs 2025; 85: 557-570
125672 Time spent on eye disease screening, optical care, and care navigation within a federally qualified health center
Livingston J
AJO international 2025; 2:
125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
Mungle T
Ophthalmology science 2025; 5: 100717
125065 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs
Ramachandran R
Ophthalmology 2025; 132: 1033-1044
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Christie WC
Drugs 2025; 85: 557-570
125672 Time spent on eye disease screening, optical care, and care navigation within a federally qualified health center
Zuccaro MS
AJO international 2025; 2:
125118 Enhanced Phenotype Identification of Common Ocular Diseases in Real-World Datasets
Bicket AK
Ophthalmology science 2025; 5: 100717
125065 Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs
Johnson L
Ophthalmology 2025; 132: 1033-1044
126960 Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
Bicket AK; Gous PNJ
Drugs 2025; 85: 557-570
